8 completed, 2 recruiting. 6 Phase 3, 2 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Not applicable | 2 | Recruiting 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow HIB: new trials by email Literature Review of HIB trials Research Report on HIB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eco-guided Neuromodulation of the Femoral Nerve on the Performance of Amateur Athletes. Theta Burst Protocol, 10-10-10 Protocol, 5-55 Protocol - Healthy Volunteers, Neuromuscular Function | Not applicable | Recruiting | Universitat Internacional de Catalunya | 23 | 2026-09-01 | 2026-07-22 |
| Multi-Site Feasibility Testing a Meditation App for Youth in the Legal System Bodhi AIM, HIB - Behavioral Health | Not applicable | Recruiting | University of Illinois at Chicago | 120 | 2026-07-30 | 2026-08-07 |
| Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines PCV13, DTaP, HBV - Apnea, Apnea Neonatal | Phase 4 | Completed | Duke University | 223 | 2018-07-17 | 2024-02-14 |
| A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children 13vPnC, Hib - Pneumococcal Infections, Pneumococcal Conjugate Vaccine | Phase 3 | Completed | Pfizer | 936 | 2018-06-23 | 2024-11-05 |
| Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine GSK Biologicals' Synflorix™ (Pneumococcal vaccine GSK1024850A), Wyeth-Lederle's Prevenar™, GSK Biologicals' Hiberix™ - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 450 | 2009-06-11 | 2018-09-20 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age Pneumococcal conjugate vaccine GSK1024850A, Tritanrix-HepB/Hib, Hiberix - Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Completed | GlaxoSmithKline | 360 | 2009-03-07 | 2020-01-03 |
| Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™ Pneumococcal vaccine GSK1024850A (Synflorix), Prevenar, GSK Biologicals' Hiberix™ - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 503 | 2008-06-10 | 2018-06-08 |
| B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants MenACWY-CRM, DTaP-Hib-IPV, PCV - Meningococcal Disease | Phase 2 | Completed | Novartis Vaccines | 216 | 2007-07-01 | 2014-10-01 |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants Meningococcal ACWY Conjugate Vaccine, DTaP-IPV-HBV, Hib - Meningitis, Meningococcal | Phase 3 | Completed | Novartis Vaccines | 4545 | 2007-03-01 | 2014-03-24 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine Pneumococcal conjugate vaccine GSK1024850A, Prevenar, Tritanrix-HepB - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 806 | 2006-08-07 | 2018-12-07 |
Pneumococcal Infections (4) · Streptococcal Infections (4) · Meningococcal Infections (2) · Apnea (1) · Meningitis (1) · Meningitis, Meningococcal (1) · Premature Birth (1)
GlaxoSmithKline (4) · Novartis Vaccines (2) · Duke University (1) · Pfizer (1) · Universitat Internacional de Catalunya (1) · University of Illinois at Chicago (1)
United States (3) · South Korea (2) · Argentina (1) · China (1) · Colombia (1) · India (1) · Philippines (1) · Poland (1) · Spain (1) · United Kingdom (1)
Andrea Trembath, MD (1) · Karen Broder, MD (1) · Mary A Staat, MD (1) · Rachel G Greenberg, MD (1)
PMID 19325447, PMID 19325451, PMID 19325452, PMID 22094635, PMID 23566945, PMID 25008901, PMID 37549923, PMID 39761016
R01AT012892 (1)